Brief: Hungary's Richter and Hetero announce cooperation for development of semaglutide injection
10/06/2026 07:04
BRIEF-Hungary's Richter and Hetero announce cooperation for development of semaglutide injection June 10 (Reuters) - Richter Gedeon Vegyeszeti Gyar Nyrt GDRB.BU says in a statement:
HUNGARY'S RICHTER AND HETERO LABS ANNOUNCE GLOBAL COOPERATION FOR THE DEVELOPMENT AND COMMERCIALIZATION OF SEMAGLUTIDE INJECTION, A GENERIC OF OZEMPIC
REGULATORY FILINGS ARE UNDERWAY WITH EU AND US SUBMISSIONS PLANNED FOR 2027
Source text: [https://www.bse.hu/newkibdata/129479551/Hetero_semaglutide_Jun2026_EN.pdf]
Further company coverage: GDRB.BU
(Reporting by Anita Komuves)
((KOMUVES.Anita@thomsonreuters.com;))
Recent news on Gedeon Richter
See all newsBrief: Hungary's Richter says US FDA accepted for review its new drug application for Fylrevy
Brief: Hungary's Richter Upgrades 2026 Pharma Clean EBIT Guidance To Double-Digit Growth
development partnership in Tirzepatide
AI in Hungary could unlock productivity gains of €15 billion, McKinsey says
Brief: Hungary's Richter and Hetero announce cooperation for development of semaglutide injection